Breaking News
Get 50% Off 0
🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% Off CLAIM SALE
Close

Taiko Pharmaceutical Co Ltd (4574)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
427.0 +4.0    +0.95%
05/07 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3442200006 
  • Volume: 256,800
  • Bid/Ask: 427.0 / 428.0
  • Day's Range: 423.0 - 433.0
Taiko Pharmaceutical 427.0 +4.0 +0.95%

4574 Balance Sheet

 
Featured here, the Balance Sheet for Taiko Pharmaceutical Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 8764 9109 8869 8514
Cash and Short Term Investments 5238 5484 4776 4782
Cash - - - -
Cash & Equivalents 5238 5484 4776 4782
Short Term Investments - - - -
Total Receivables, Net 1935 1985 2273 1685
Accounts Receivables - Trade, Net 1935 1985 2273 1685
Total Inventory 1472 1373 1588 1839
Prepaid Expenses - - - -
Other Current Assets, Total 119 267 232 208
Total Assets 12997 13220 15812 15636
Property/Plant/Equipment, Total - Net 3548 3581 5927 6113
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net 20 1 168 177
Long Term Investments 663 526 846 830
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 2 2 2 2
Other Assets, Total -344 -344 -453 362
Total Current Liabilities 2500 3046 2778 2888
Accounts Payable 338 375 415 350
Payable/Accrued - - - -
Accrued Expenses 26 75 78 53
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 1276 1233 1109 969
Other Current liabilities, Total 860 1363 1176 1516
Total Liabilities 5573 6482 6050 6460
Total Long Term Debt 1627 2021 1870 2200
Long Term Debt 1627 1999 1870 2200
Capital Lease Obligations - 22 - -
Deferred Income Tax - 188 - -
Minority Interest - - - -
Other Liabilities, Total 1446 -1978 -1577 1372
Total Equity 7424 6738 9762 9176
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 2297 2267 2204 1918
Additional Paid-In Capital 2719 2689 2626 2340
Retained Earnings (Accumulated Deficit) 2100 1628 4676 4724
Treasury Stock - Common -300 -300 -300 -300
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 608 454 556 494
Total Liabilities & Shareholders' Equity 12997 13220 15812 15636
Total Common Shares Outstanding 50.15 49.95 48.95 47.03
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4574 Comments

Write your thoughts about Taiko Pharmaceutical Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email